Diagnostic and Clinical Utility of the 2‐Item Patient Health Questionnaire (PHQ‐2) for Screening Depressive Symptoms in Individuals With Persistent Musculoskeletal Pain Attending Physiotherapy
Musculoskeletal Care · 2025
DOI: 10.1002/msc.70113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Musculoskeletal Care, 2025. Verfasst von Davy Vancampfort und 6 weiteren Autor:innen. Beteiligte Einrichtung: KU Leuven Department of Rehabilitation Sciences, Leuven, Belgium. Hauptthemen laut MEDLINE: Musculoskeletal Pain, Depression, Patient Health Questionnaire, Physical Therapy Modalities. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Themen: Depression
Abstract (Originalsprache)
Introduction
This cross‐sectional study evaluates the diagnostic and clinical utility of the two‐item Patient Health Questionnaire (PHQ‐2) for screening depressive symptoms in individuals with persistent musculoskeletal pain attending physiotherapy.
Methods
A total of 450 patients (mean age = 53.3 ± 12.2 years; 109 male) with persistent musculoskeletal pain were recruited from 84 private physiotherapy practices. Participants completed both the PHQ‐9 and PHQ‐2. Internal consistency was assessed using Cronbach's alpha. Receiver operating characteristic curve analysis and Youden's J identified the optimal PHQ‐2 cutoff score. Chi‐square tests examined physiotherapists' intentions to provide advice or refer patients based on PHQ‐2 scores.
Results
Internal consistency was good for the PHQ‐9 ( α = 0.85) and acceptable for the PHQ‐2 ( α = 0.71). A strong correlation was found between PHQ‐2 and PHQ‐9 scores ( r = 0.51, p < 0.001). PHQ‐2 showed moderate accuracy for detecting significant depressive symptoms (AUC = 0.74, 95% CI: 0.70–0.78). A cutoff score of ≥ 1 balanced sensitivity (74%) and specificity (62%). Physiotherapists were more likely to provide advice (85.9% vs. 72.9%, χ 2 (1) = 11.1, p < 0.001) and recommend additional support (45.8% vs. 18.8%, χ 2 (1) = 30.6, p < 0.001) when patients scored at or above this cutoff.
Discussion
PHQ‐2 is a brief, clinically useful tool with acceptable psychometric properties for screening depressive symptoms in patients with persistent pain in physiotherapy settings.
Conclusions
PHQ‐2 shows promise as a quick screening tool to identify patients with musculoskeletal pain who may need mental health support.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- KU Leuven Department of Rehabilitation Sciences, Leuven, Belgium.
- University Psychiatric Centre KU Leuven, Leuven, Belgium.
- Leuven Brain Institute, Leuven, Belgium.
- La Trobe Rural Health School, La Trobe University, Bendigo, Australia.
- Department of Rural Health, The University of Melbourne, Shepparton, Australia.
- Allied Health Education and Research Unit, Goulburn Valley Health, Shepparton, Australia.
ORCID-Profile: Davy Vancampfort
Zitieren
APA
Vancampfort, D., McGrath, R. L., Dankaerts, W., Van Assche, D., Lambrechts, M., Stubbs, B., & Van Damme, T. (2025). Diagnostic and Clinical Utility of the 2‐Item Patient Health Questionnaire (PHQ‐2) for Screening Depressive Symptoms in Individuals With Persistent Musculoskeletal Pain Attending Physiotherapy. Musculoskeletal Care. https://doi.org/10.1002/msc.70113
Vancouver
Vancampfort D, McGrath RL, Dankaerts W, Van Assche D, Lambrechts M, Stubbs B, et al. Diagnostic and Clinical Utility of the 2‐Item Patient Health Questionnaire (PHQ‐2) for Screening Depressive Symptoms in Individuals With Persistent Musculoskeletal Pain Attending Physiotherapy. Musculoskeletal Care. 2025. doi:10.1002/msc.70113
BibTeX
@article{Vancampfort2025,
author = {Vancampfort, Davy and McGrath, Ryan L and Dankaerts, Wim and Van Assche, Dieter and Lambrechts, Monica and Stubbs, Brendon and Van Damme, Tine},
title = {Diagnostic and Clinical Utility of the 2‐Item Patient Health Questionnaire (PHQ‐2) for Screening Depressive Symptoms in Individuals With Persistent Musculoskeletal Pain Attending Physiotherapy},
journal = {Musculoskeletal Care},
year = {2025},
doi = {10.1002/msc.70113}
}
EUVIMED